The present invention encompasses compounds of general formula (1)
wherein
R
2
to R
5
and X are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a pharmaceutical composition having the above-mentioned properties.